Abstract: Synthesis of new 1,2-dihydro-3H-pyrazolo [3,4-d] pyrimidin-3-ones 4-6 starting with ethyl 4-hydroxy-2-methylthio-pyrimidine-5-carboxylate (1) under classical heating and microwave-induced conditions is reported. The antibacterial activities of the synthesized compounds were evaluated using chloramphenicol and streptomycin as reference drugs.
Introduction
Pyrazolo [3,4-d] pyrimidines and related fused derivatives are a pharmaceutically important class of compounds [1] . They exhibit diverse pharmaceutical activities such as antifungal [2] , antibacterial [2, 3] , neuroleptic [4] , antihypertensive [5] and antileishmanial [6] properties. Also, pyrazolopyrimidines have been exploited as ATP competitive inhibitors of kinases [7] , cAMP phosphodiesterase [8] and DNA polymerase [9] . Some of these compounds have demonstrated antitumor activities [10] by inhibiting different types of enzymes such as cyclin-dependent kinase [10, 11, 12] adenosine deaminase [12] glycogen synthase kinase-3 [13] and epidermal growth factor receptor protein tyrosine kinase [14] .
Most synthetic approaches to pyrazolopyrimidines start from substituted pyrimidines or pyrazoles [15] . The cyclization of pyrimidines with hydrazines provides pyrazolopyrimidines via the construction of the fused pyrazole ring [16] . Alternatively, pyrazolopyrimidines can also be synthesized through the construction of the pyrimidine ring using substituted pyrazoles [10] . Recently, some new methods have been reported based on using microwave irradiation [16] , ionic liquids [17] , supported solid catalysts [17, 18] and under solvent-free conditions [19] .
As part of our ongoing program aimed at developing new protocols for preparation of biologically active heterocyclic compounds [20] , we wish to report the result of our investigations on the synthesis and antimicrobial activities of new derivatives of pyrazolo [3,4-d] pyrimidin-3(2H)-ones.
Results and discussion
The starting material, ethyl 4-hydroxy-2-methylthio-pyrimidine-5-carboxylate (1 in Scheme 1), was prepared according to the previously published method [21] . The treatment of 1 with morpholine, pyrolidine and piperidine, led to the selective S N Ar displacement of the thiomethyl moiety and gave the respective pyrimidines 2a-c. Then, the chloropyrimidines 3a-c were obtained by heating compounds 2a-c in a mixture of PCl 5 and POCl 3 (1:14) [22] [23] [24] . Compounds 3a-c served as direct precursors to the desired products 4a-c, 5a-c and 6a-c by the reaction with hydrazine, methylhydrazine and phenylhydrazine, respectively. Classical synthesis of pyrazolo[1,5-a]pyrimidines 4-6 was performed by heating the reactants in ethanol in the presence of sodium ethoxide (Method A in Scheme 1). The observed different regioselectivities for the reaction with methylhydrazine to give product 5 and for the reaction with phenylhydrazine leading to product 6 are in full agreement with the literature data [25] [26] [27] . A similar, microwave-assisted organic synthesis (MAOS) [28, 29] is designated in Scheme 1 as Method B. Comparison of the results of the two methodologies reveals that the use of microwave irradiation greatly reduces the reaction time (from 2-8 h to 2-6 min) and significantly increases the yield. The structures of products 4-6 are fully supported by the results of IR, 1 H NMR, 13 C NMR, MS and elemental analysis. A literature survey [30, 31] reveals that synthetic approaches to pyrazolopyrimidines mostly involve a heterocyclization reaction of pyrimidine moiety onto the pyrazole core [15] . Our synthetic protocol is different and based on the construction of the pyrazole moiety at the pyrimidine core.
Compounds 4-6 were tested for antibacterial activity against Gram-positive (Staphylococcus aureus ATCC 25923, Bacillus cereus ATCC 11778) and Gram-negative (Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 9027) bacteria. The results of antibacterial properties of active compounds are shown in Table 1 . The results indicate that compound 6c shows the strongest antibacterial properties against all tested bacteria. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of compound 6c against E. coli are significantly better than those of chloramphenicol, the reference drug. Inhibition activity of 6c against P. aeruginosa is the same as that of streptomycin. Finally, the antibacterial activity of 6c against S. aureus is higher than that of chloramphenicol and is equal to streptomycin.
Conclusion
In summary, we applied classical conditions and MAOS to the preparation of pyrazolo [3,4- 4a-c, 5a-c and 6a-c. In all cases, reaction times and yields of products were dramatically improved under the MAOS protocol. Compound 6c has a very good antimicrobial activity compared to chloramphenicol and streptomycin.
Experimental
Melting points were recorded on an Electrothermal type 9100 melting point apparatus. The IR spectra were obtained in KBr discs on an Avatar 370 FT-IR Thermo Nicolet instrument. The 1 H NMR (400 MHz) and the 13 C NMR (100 MHz) spectra were recorded in DMSO-d 6 on a Bruker Avance DRX-400 spectrometer. The electron impact mass spectra were scanned on a Varian Mat CH-7 instrument at 70 eV. Elemental analyses were performed on a Thermo Finnigan Flash EA microanalyzer. The in vitro antibacterial activities of the compounds were determined using the broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) recommended MIC protocol with minor modifications [32] . The minimum bactericidal concentrations (MBC) we also determined [33] . Volumes of 5 μL of every well without growth were transferred to agar plates and incubated at 37°C for 24 h. The lowest concentration of the synthetic compounds where no viable bacteria were identified was taken as MBC [33] .
General procedure for the synthesis of compounds 3a-c
Phosphorus pentachloride (2.7 mmol, 0.5 g) was added to a suspension of ethyl 2-(substituted)amino-6-oxo-1,6-dihydropyrimidine-5-carboxylate (3.5 mmol, 1.0 g) in phosphorus oxychloride (7 mL). After the mixture had been heated under reflux for 3 h, the residue was cooled and poured onto ice (~30 g). The resulting solid was filtrated and crystallized from petroleum ether. -1-yl) 
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General procedures for the synthesis of 4a-c, 5a-c and 6a-c
Method A A solution of sodium ethoxide obtained from sodium metal (1 mmol, 0.023 g)] and absolute ethanol (5 mL) was treated with 3a-c (1 mmol) and hydrazine, methylhydrazine or phenylhydrazine (1.2 mmol). The mixture was heated on a water bath at 60°C and, after completion of the reaction as was monitored by TLC using CHCl 3 / MeOH (20:1), the solvent was removed under reduced pressure. The solid residue was dissolved in water and the solution acidified with acetic acid. The resulting precipitate was filtered, washed with water (2 × 30 mL), dried and crystallized from methanol to give the product 4a-c, 5a-c or 6a-c.
Method B A mixture of compound 3a-c (1 mmol) and an excess amount of the appropriate hydrazine (0.1 mL) was subjected to microwave irradiation in the absence of solvent (maximum power 400W during 2-6 min at room temperature) using a focused microwave reactor (Milestone). After the completion of the reaction, water (5 mL) was added. The solid product was collected by filtration and crystallized from methanol to give the corresponding compounds 4a-c, 5a-c or 6a-c. -1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d -6-(piperidin-1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d -6-(piperidin-1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d 
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